A young woman died in Germany after vaccination from Coronavirus drug developed by the British-Swedish company Astrazeneca together with Oxford University. It is reported by WDR.
The incident occurred in the county of Herford in the federal land North Rhine – Westphalia. 32-year-old German died on March 9, a few days after vaccination against COVID-19. The autopsy and an additional study of the body confirmed the suspicion that it died from side effects: the cause of death was the violation of blood coagulation with subsequent hemorrhage into the brain.
In Herford, they stated that they were deeply concerned about what happened. “With the help of vaccination, she wanted to protect himself and, above all, other people,” indicated in the district administration.
Earlier, the first death case after the Astrazeneca vaccine was recorded in Canada. Prior to that, it was reported that in the UK for the week almost twice the number of those who had thrombus formed after the administration of the drug from Astrazeneca.
Some countries in Europe, including Germany, suspended or banned vaccination with Astrazeneca due to discovery of thrombosis in the intimidated patients. Meanwhile, the creators of the vaccine insist on its safety. The company stated that a detailed study of the health of more than 17 million people after vaccination showed the absence of data on increased risk of pulmonary artery embolism, deep veins thrombosis or thrombocytopenia.